Cleared Traditional

K110770 - HEALTHTRACKER

K110770 is the FDA 510(k) clearance for HEALTHTRACKER by Wistron Corporation. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 243-day FDA review.

K110770 · Wistron Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2011
Decision
243d
Days
Class 2
Risk

K110770 is an FDA 510(k) clearance for the HEALTHTRACKER. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Wistron Corporation (Taipei County, TW). The FDA issued a Cleared decision on November 16, 2011 after a review of 243 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Wistron Corporation devices

Submission Details

510(k) Number K110770 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 2011
Decision Date November 16, 2011
Days to Decision 243 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
118d slower than avg
Panel avg: 125d · This submission: 243d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K110770.
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K111826 · Andon Health Co, Ltd. · Dec 2011
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR MODEL KD-7902BTJ, FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR MO
K111830 · Andon Health Co, Ltd. · Dec 2011
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR
K112845 · Microlife Intellectual Property GmbH · Dec 2011
SURESIGNS VS2+ -SURESIGNS VSI
K112652 · Philips Medical Systems · Oct 2011
FULL AUTOMATIC (NIBP) BLOOD PRESSURE MONITOR
K112320 · Health & Life Co., Ltd. · Sep 2011
MICROLIFE AUTOMATIC TALKING BLOOD PRESSURE MONITOR
K111652 · Microlife Intellectual Property GmbH · Jul 2011